Why the study?
The ESC/ACC redefined myocardial infarction as any amount of necrosis caused by ischaemia, creating a need to describe real-world management and 1-year outcomes of STEMI and NSTEMI under the new definition.
Does STEMI presentation compared to NSTEMI presentation result in different 1-year outcomes in patients with acute myocardial infarction?
Does STEMI presentation compared to NSTEMI presentation result in different 1-year outcomes in patients with acute myocardial infarction?
Despite different management strategies, STEMI and NSTEMI patients have similar in-hospital and 1-year mortality, supporting the unified ESC/ACC definition of myocardial infarction.
Answers are grounded in this paper and cite their sources.
Similar mortality in STEMI and NSTEMI supports unified MI definition; leaves open whether management differences affect outcomes in broader cohorts.
AIMS: The ESC/ACC redefined myocardial infarction as any amount of necrosis caused by ischaemia. The aim of this study was to describe the management and outcomes using 'real-world' data taking the new definition of acute myocardial infarction into account. METHODS AND RESULTS: A total of 2,151 consecutive patients (76.0% men) with a myocardial infarction were enrolled at 56 centres in France. The median delay to presentation was shorter in patients with ST-segment elevation myocardial infarction (STEMI) vs. non-STEMI (NSTEMI) (4 vs. 7 h, P < 0.0001). STEMI patients were more likely to receive fibrinolysis (28.9 vs. 0.7%, P < 0.0001) or undergo PCI (71.0 vs. 51.6%, P < 0.0001) but less likely to have bypass surgery (3.1 vs. 4.9%, P < 0.05). At discharge, patients with STEMI received more aggressive secondary prevention therapies than those with NSTEMI, which was not supported by differences in disease severity. A total of 1878 patients were followed-up for 1 year: 36.7% of STEMI and 41.5% of NSTEMI patients were rehospitalized (P = 0.05); 16% in both groups were revascularized. In-hospital mortality was similar (4.6 vs. 4.3%), and 1-year mortality was 9.0% in STEMI patients and 11.6% in NSTEMI patients (Log-Rank P = 0.09). Independent correlates of in-hospital mortality were untreated dyslipidaemia, advanced age, diabetes, and low blood pressure. The strongest predictors of 1-year mortality were heart failure and age. Similar predictors were found in STEMI and NSTEMI subgroups. CONCLUSIONS: Despite different management, patients with STEMI and NSTEMI have similar prognoses and independent correlates of outcome. These findings support the new definition of myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Montalescot et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: